Literature DB >> 29672879

Increased left atrial size is associated with higher atrial fibrillation recurrence in patients treated with antiarrhythmic medications.

Saarang Mulukutla1, Andrew D Althouse1, Sandeep K Jain1, Samir Saba1.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is highly prevalent, and antiarrhythmic therapy is often used to help with rhythm control. Some common echocardiographic parameters may be useful in predicting AF recurrence among these patients. The purpose of this study was to evaluate the association between 3 common echocardiographic parameters (left atrial [LA] size, left ventricular ejection fraction [LVEF], and mitral regurgitation [MR]) and AF recurrence among patients treated with antiarrhythmic medications. HYPOTHESIS: We hypothesized that LA size, LVEF, and severity of MR are predictors of AF recurrence in this population.
METHODS: A real-world cohort of AF patients who had transthoracic echocardiograms was analyzed. Data on LA size, LVEF, and MR were collected retrospectively from echocardiography reports. Patients were followed from the time of the echocardiogram until first recurrence of AF.
RESULTS: A total of 2522 patients had echocardiography reports available for review. LA size showed the strongest prognostic relationship with AF recurrence; neither LVEF nor MR was significantly associated with AF recurrence. These results persisted after adjusting for age, sex, race, tobacco use, alcohol use, drug use, body mass index, and Charlson Comorbidity Index in a multivariable model.
CONCLUSIONS: In a cohort of patients treated with antiarrhythmic medications that had transthoracic echocardiogram data, LA size was a significant predictor of AF recurrence. The clinical utility of this finding would be strengthened by replication in a multicenter setting.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Atrial Fibrillation; Echocardiography; Left Atrial Size; Recurrence; Rhythm Control

Mesh:

Substances:

Year:  2018        PMID: 29672879      PMCID: PMC6490118          DOI: 10.1002/clc.22964

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  30 in total

1.  Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study.

Authors:  Brian Olshansky; Eliot N Heller; L Brent Mitchell; Mary Chandler; William Slater; Martin Green; Michael Brodsky; Patrick Barrell; H Leon Greene
Journal:  J Am Coll Cardiol       Date:  2005-06-21       Impact factor: 24.094

2.  Cardiac performance early after cardioversion from atrial fibrillation.

Authors:  R J Raymond; A J Lee; F C Messineo; W J Manning; D I Silverman
Journal:  Am Heart J       Date:  1998-09       Impact factor: 4.749

Review 3.  Atrial fibrillation pathophysiology: implications for management.

Authors:  Yu-ki Iwasaki; Kunihiro Nishida; Takeshi Kato; Stanley Nattel
Journal:  Circulation       Date:  2011-11-15       Impact factor: 29.690

4.  Effects of experimental heart failure on atrial cellular and ionic electrophysiology.

Authors:  D Li; P Melnyk; J Feng; Z Wang; K Petrecca; A Shrier; S Nattel
Journal:  Circulation       Date:  2000-06-06       Impact factor: 29.690

5.  Indexed left atrial volume predicts the recurrence of non-valvular atrial fibrillation after successful cardioversion.

Authors:  Procolo Marchese; Francesca Bursi; Grazia Delle Donne; Vincenzo Malavasi; Edoardo Casali; Andrea Barbieri; Francesco Melandri; Maria Grazia Modena
Journal:  Eur J Echocardiogr       Date:  2010-12-11

6.  Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Authors:  Merritt H Raitt; Annabelle S Volgman; Robert G Zoble; Lyne Charbonneau; Farooq A Padder; Gilles E O'Hara; David Kerr
Journal:  Am Heart J       Date:  2006-02       Impact factor: 4.749

7.  Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter.

Authors:  S A Roberts; C Diaz; P E Nolan; D M Salerno; J S Stapczynski; A S Zbrozek; E G Ritz; J L Bauman; P H Vlasses
Journal:  Am J Cardiol       Date:  1993-09-01       Impact factor: 2.778

8.  Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.

Authors:  S M Vaziri; M G Larson; E J Benjamin; D Levy
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

Review 9.  A review of atrial fibrillation.

Authors:  David Dang; Raluca Arimie; L Julian Haywood
Journal:  J Natl Med Assoc       Date:  2002-12       Impact factor: 1.798

10.  Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.

Authors:  Sumeet S Chugh; Rasmus Havmoeller; Kumar Narayanan; David Singh; Michiel Rienstra; Emelia J Benjamin; Richard F Gillum; Young-Hoon Kim; John H McAnulty; Zhi-Jie Zheng; Mohammad H Forouzanfar; Mohsen Naghavi; George A Mensah; Majid Ezzati; Christopher J L Murray
Journal:  Circulation       Date:  2013-12-17       Impact factor: 29.690

View more
  4 in total

1.  Increased left atrial size is associated with higher atrial fibrillation recurrence in patients treated with antiarrhythmic medications.

Authors:  Saarang Mulukutla; Andrew D Althouse; Sandeep K Jain; Samir Saba
Journal:  Clin Cardiol       Date:  2018-06-07       Impact factor: 2.882

2.  Predicting Values of Neutrophil-to-Lymphocyte Ratio (NLR), High-Sensitivity C-Reactive Protein (hs-CRP), and Left Atrial Diameter (LAD) in Patients with Nonvalvular Atrial Fibrillation Recurrence After Radiofrequency Ablation.

Authors:  Bing Ding; Pengfei Liu; Fangfang Zhang; Jie Hui; Linyan He
Journal:  Med Sci Monit       Date:  2022-01-27

3.  Qualitative Evaluation of an Artificial Intelligence-Based Clinical Decision Support System to Guide Rhythm Management of Atrial Fibrillation: Survey Study.

Authors:  John Stacy; Rachel Kim; Christopher Barrett; Balaviknesh Sekar; Steven Simon; Farnoush Banaei-Kashani; Michael A Rosenberg
Journal:  JMIR Form Res       Date:  2022-08-11

4.  Left Atrial Size; a Missing Component in Scoring Systems for Predicting Atrial Fibrillation Following Coronary Artery Bypass Surgery.

Authors:  Abbasali Karimi; Hamidreza Goodarzynejad; Seyedeh Hamideh Mortazavi; Peyvand Bina; Arash Jalali; Abbas Salehi Omran; Seyed Hossein Ahmadi Tafti; Kyomars Abbasi; Ali Hossein Sabet; Saeed Sadeghian
Journal:  Acta Cardiol Sin       Date:  2020-09       Impact factor: 2.672

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.